What this case does and does not establish

What the evidence supports: this result set fits a metabolic-syndrome pattern under both the 2001 ATP III and 2009 harmonized criteria because four independently scored criteria are met, including fasting glucose, while waist remains unscored because the applicable population cutoff is not supplied. The 14-day CGM report meets the aggregate active-time recommendation, but individual events still need review. Different windows can contribute to the GMI/A1c gap; interference, red-cell effects, and missingness must also be reviewed before either result is assumed correct.

What it does not establish: this pattern is not a diabetes diagnosis. Diabetes has its own separate, higher thresholds (FPG 126 mg/dL or higher, A1c 6.5% or higher, and so on) and generally requires two abnormal results absent unequivocal hyperglycemia; none of that confirmatory testing was described here. The CGM data cannot substitute for or override the laboratory A1c, and GMI has no single universal numeric target of its own; current ADA guidance treats it as one metric to read alongside TIR, time below range, time above range, and laboratory A1c, not a replacement for any of them.

What depends on method and local policy: the exact criteria version and waist cut point a given laboratory or ordering group has adopted for interpretive comments, whether the laboratory issues an interpretive comment at all versus discrete values only, the local fasting-instruction and glycolysis-inhibitor tube validation for lipid and glucose draws. The MARD and warm-up figures are specific to one FDA-cleared device and do not transfer to a different CGM system without checking that device's own labeling.

A laboratory result answers a specific, bounded question; the value of this case is in stating clearly which question each number answers, not in forcing every number toward one tidy label.